De Novo device
Prapela SVS hospital bassinet pad (model P01)
Prapela, Inc. · Therapeutic Vibrational Mattress Pad, Adjunct Use In Neonatal Abstinence Syndrome Or Neonatal Opioid Withdrawal Syndrome (QVY, Class II) · First FDA decision Apr 4, 2025, newest Apr 4, 2025
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
De Novo pathway
Device trials
0
Naming "SVS hospital bassinet"
MAUDE reports
0
Brand "SVS hospital bassinet", since 2015
PubMed studies
0
Mentioning "SVS hospital bassinet"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Prapela SVS hospital bassinet pad (model P01)
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 0 of 1 decisions filed under this name.
FDA's records could not be loaded.
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Dermal injections for the treatment of facial lipodystrophy syndrome (FLS)National analysisReview closedCAG-00412NUpdated Nov 19, 2026
- Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Myelodysplastic Syndromes (MDS)National analysisReview closedCAG-00415RUpdated Nov 19, 2026
- Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Myelodysplastic SyndromeNational analysisReview closedCAG-00415NUpdated Nov 19, 2026
- Serum Iron Studies (Addition of Restless Leg Syndrome as a Covered Indication)National analysisReview closedCAG-00263RUpdated Sep 23, 2026
- Dermal Injections for the Treatment of Facial Lipodystrophy Syndrome (LDS)National determinationOn the books250.5Updated Sep 9, 2025
- Serologic Testing for Acquired Immunodeficiency Syndrome (AIDS)National determinationOn the books190.9Updated Mar 9, 2018
- MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with CancerLocal determinationIn effectL39040WPS Insurance CorporationUpdated Mar 20, 2026
- MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with CancerLocal determinationIn effectL39017CGS Administrators, LLCUpdated Mar 9, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "SVS hospital bassinet", any status and sponsor, newest update first.
No registered device study names "SVS hospital bassinet".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "SVS hospital bassinet", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code QVY
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "SVS hospital bassinet"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.